Evaluation of Malignancy Risk in Scleroderma by Antibody Profile
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of Malignancy Risk in Scleroderma by Antibody Profile
Br J Dermatol 2020 Sep 13;[EPub Ahead of Print], C Lertphanichkul, GP SmithFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.